Rhenman & Partners Asset Management’s Kite Pharma, Inc. KITE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-60,000
| Closed | -$6.22M | – | 118 |
|
|
2017
Q2 | $6.22M | Sell |
60,000
-50,000
| -45% | -$5.18M | 0.89% | 44 |
|
|
2017
Q1 | $8.63M | Buy |
110,000
+30,000
| +38% | +$2.35M | 1.37% | 30 |
|
|
2016
Q4 | $3.59M | Sell |
80,000
-10,000
| -11% | -$448K | 0.69% | 56 |
|
|
2016
Q3 | $5.03M | Buy |
90,000
+20,000
| +29% | +$1.12M | 0.8% | 47 |
|
|
2016
Q2 | $3.5M | Buy |
+70,000
| New | +$3.5M | 0.62% | 60 |
|
|
2015
Q4 | – | Sell |
-57,000
| Closed | -$3.17M | – | 100 |
|
|
2015
Q3 | $3.17M | Sell |
57,000
-9,000
| -14% | -$501K | 0.51% | 62 |
|
|
2015
Q2 | $4.02M | Buy |
66,000
+21,000
| +47% | +$1.28M | 0.48% | 68 |
|
|
2015
Q1 | $2.6M | Buy |
45,000
+10,000
| +29% | +$577K | 0.44% | 79 |
|
|
2014
Q4 | $2.02M | Buy |
+35,000
| New | +$2.02M | 0.58% | 75 |
|